EUVIMEDEUVIMED entdecken
Crossref

Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertension

Dhruvanshi Gol, Amitkumar Vyas, Nilam Visana, Ajay Patel, Sunny Shah, Devang Sheth, Sandip Dholakia

Annales Pharmaceutiques Françaises · 2024

DOI: 10.1016/j.pharma.2023.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2024. Verfasst von Dhruvanshi Gol und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Quality Assurance, B.K. Mody Government Pharmacy College, Polytechnic campus, Near Aji dam, Rajkot, 360003, Gujarat, Ind…. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Pyrimidines, Sulfonamides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: High Performance liquid chromatography is an integral analytical tool in assessing drug product stability. A simple, selective, precise, accurate and stability indicating RP-HPLC method was developed and validated for analysis of Tadalafil and Macitentan in synthetic mixture. MATERIAL AND METHOD: Chromatographic separation was performed using Phenomex Gemini C18 (25cm×4.6nm, 5μm) Column. The mobile phase consists of (10mM Ammonium Acetate in water and [Methanol: ACN 20: 80% v/v]) (40: 60% v/v). The flow rate was set to be 1.0mL/min. The injection volume was 10.00μL. The detection was carried out at 260nm at column temperature 35°C. RESULTS: The method was validating according to ICH Q2R1 guideline for accuracy, precision, reproducibility, specificity, robustness and detection and quantification limits. Stability testing was performed on Tadalafil and Macitentan and it was found that these degraded sufficiently in all applied chemical and physical conditions. Linearity for Tadalafil and Macitentan was observed 0.4-100μg/mL and 0.1-25μg/mL with correlation coefficient at 0.9999. LOD and LOQ 0.008μg/mL and 0.024μg/mL and 0.001μg/mL and 0.0029μg/mL for Tadalafil and Macitentan respectively. CONCLUSION: The developed RP-HPLC method was found to be suitable for the determination of both the drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Arterial HypertensionPyrimidinesSulfonamidesHumansChromatography, High Pressure LiquidTadalafilReproducibility of ResultsDrug Stability

Stichwörter der Autor:innen

Hypertension artérielle pulmonaireIndicateur de stabilitéMacitentanMélange synthétiquePulmonary arterial hypertensionStability indicatingSynthetic mixtureTadalafil

Substanzen

TadalafilmacitentanPyrimidinesSulfonamides

Autor:innen und Institutionen

  • Department of Pharmaceutical Quality Assurance, B.K. Mody Government Pharmacy College, Polytechnic campus, Near Aji dam, Rajkot, 360003, Gujarat, India. Electronic address: dhruvanshigol4064@gmail.com.
  • Department of Pharmaceutical Quality Assurance, B.K. Mody Government Pharmacy College, Polytechnic campus, Near Aji dam, Rajkot, 360003, Gujarat, India.
  • L.M. College of Pharmacy, Ahmedabad, Gujarat, India.

Zitieren

APA

Gol, D., Vyas, A., Visana, N., Patel, A., Shah, S., Sheth, D., & Dholakia, S. (2024). Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertension. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2023.10.006

Vancouver

Gol D, Vyas A, Visana N, Patel A, Shah S, Sheth D, et al. Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertension. Annales Pharmaceutiques Françaises. 2024. doi:10.1016/j.pharma.2023.10.006

BibTeX
@article{Gol2024,
  author = {Gol, Dhruvanshi and Vyas, Amitkumar and Visana, Nilam and Patel, Ajay and Shah, Sunny and Sheth, Devang and Dholakia, Sandip},
  title = {Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertension},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2024},
  doi = {10.1016/j.pharma.2023.10.006}
}
Kostenlos starten →